Pages that link to "Q42988437"

The following pages link to Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients (Q42988437):

Displaying 39 items.

• Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China (Q27468718) (← links)
• The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis (Q28076929) (← links)
• Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H. (Q33909717) (← links)
• Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients (Q34028878) (← links)
• Hepatocellular carcinoma in the world and the middle East (Q34134967) (← links)
• Prevalence and genotypes of hepatitis B virus infection in patients underwent coronary angiography and coronary artery bypass grafting in mazandaran heart center, sari, iran. (Q34725473) (← links)
• Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014. (Q35039134) (← links)
• Distribution of hepatitis delta virus genotypes in mashhad, northeast iran. (Q35157586) (← links)
• Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of kahramanmaras, Turkey (Q35589848) (← links)
• Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies (Q35603841) (← links)
• Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. (Q35609489) (← links)
• Genotype A2/adw2 Strain of Hepatitis B Virus in Turkey (Q35731124) (← links)
• Distribution of Hepatitis C Virus Genotypes in Bahrain. (Q36639886) (← links)
• Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis (Q37058765) (← links)
• An overview about hepatitis C: a devastating virus (Q37719516) (← links)
• A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel (Q37886280) (← links)
• Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation (Q37912229) (← links)
• Historical epidemiology of hepatitis C virus (HCV) in selected countries. (Q38203033) (← links)
• Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries (Q38459012) (← links)
• Hepatitis B genotypes in iran (Q39973986) (← links)
• Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting (Q42180462) (← links)
• Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B. (Q42217926) (← links)
• Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients (Q42218034) (← links)
• Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta (Q42233619) (← links)
• Evolutionary dynamics of HBV-D1 genotype epidemic in Turkey (Q42240346) (← links)
• Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study (Q42632231) (← links)
• Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis (Q42996683) (← links)
• Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. (Q43001516) (← links)
• Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population (Q43410546) (← links)
• Serum ferritin levels in chronic hepatitis C patients during antiviral therapy and prediction of treatment response. (Q43731496) (← links)
• Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. (Q45279478) (← links)
• Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon (Q45409040) (← links)
• Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon (Q46727946) (← links)
• Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors (Q47560767) (← links)
• Epidemiology of Chronic Hepatitis C Infections at a Tertiary Care Centre in Oman (Q49677654) (← links)
• A pilot study: longer duration of posttransplant hepatitis C virus therapy may increase the sustained response rate. (Q50561229) (← links)
• Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. (Q53664722) (← links)
• YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay. (Q54573687) (← links)
• Changes on Hepatitis C virus genotype distribution in Western Turkey: Evaluation of twelve-year data (Q90106328) (← links)